SEALSQ Receives Final Approval from the French Ministry of the Economy, Finance and Industrial and Digital Sovereignty and Completes Acquisition of IC’ALPS Geneva, Switzerland – August 4, 2025 – ...
<span>Cell Therapeutics Inc. is closer to getting French approval of Pixuvri, the company’s cancer drug. </span> Back to Top © 2025 American City Business Journals ...
Geneva, Switzerland, Aug. 04, 2025 (GLOBE NEWSWIRE) -- SEALSQ Corp (LAES) ("SEALSQ" or "Company"), a company that focuses on developing and selling Semiconductors, PKI, and Post-Quantum technology ...